Live
- Amaravati: YSRCP firm on 3Cs
- 10 Tried-and-Tested Home Remedies for Toothaches
- Thila Taila Abhishekah Pooja to Lord Shaneswara
- Sudheer Babu’s ‘Harom Hara’ set to release on this auspicious day
- Priyanka Gandhi says BJP talking of 'tinkering' with Constitution with PM’s nod
- Vishwak Sen unveils gritty avatar as ‘Lankala Rathna’ in ‘Gangs of Godavari’ teaser
- ‘Kalki 2898 AD’ locks release date; film to entertain audience from June last week
- LS polls: PM Modi says BJP-NDA leading 2-0 after first two phases
- Plea in Madras HC seeks special polling arrangement for names 'missing' from Coimbatore voter list
- Ex CM KCR Bus tour on 4 th day
Start-up India seed fund scheme: SSIIE-TBI of SPMVV gets Rs 2 Crore
SPMVV Registrar Prof N Rajani handing over the cheque to Shwetha R on Tuesday. Prof S Jyothi, Dr J Surya Kumar and others are seen.
The Society for Innovation Incubation Entrepreneurship - Technology Business Incubator (SSIIE-TBI) of Sri Padmavati Mahila Visvavidyalayam (SPMVV) secretary Prof S Jyothi said the facility was sanctioned Rs 2 crore from Start-up India Seed Fund Scheme (SISFS) of the Department for Promotion of Industry and Internal Trade.
Tirupati: The Society for Innovation Incubation Entrepreneurship - Technology Business Incubator (SSIIE-TBI) of Sri Padmavati Mahila Visvavidyalayam (SPMVV) secretary Prof S Jyothi said the facility was sanctioned Rs 2 crore from Start-up India Seed Fund Scheme (SISFS) of the Department for Promotion of Industry and Internal Trade.
They now received Rs 84 lakh as first instalment for the year 2022-2023. Under this scheme, Sarvaa Research and Innovation Private Limited, Bengaluru, has been selected as one of the start-ups to receive seed funding by the Monitoring Committee. Registrar Prof N Rajani congratulated Shwetha R, founder of the Sarvaa Research, and handed over the first tranche cheque to enable the start-up for prototype development focused in the area of postpartum depression. Some of the women after delivery experience postpartum depression which commonly include mood swings, crying spells, anxiety, difficulty in sleeping and long-lasting forms of depression. Dr J Surya Kumar, CEO, SSIIE-TBI was also present.
